��ɫ��

��ɫ��

Events

Resources For

Abstract Details

Title Oligomers That Redirect AMPA Splicing To Reduce Excitotoxicity as Potential Therapeutics for ALS

Topic Anterior Horn

Presentation(s) (-)

Poster/Presentation
Number 008

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Terry D. Heiman-Patterson, MD (Temple University Lewis Katz School of Medicine)	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Monica K. Gentchev	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Toby I. Gropen, MD (University of Alabama At Birmingham)	Dr. Gropen has nothing to disclose.